Northann (NYSE: NCL) pushed off NYSE American, eyes OTC move
Rhea-AI Filing Summary
Northann Corp. (NCL) reports that NYSE Regulation has determined its common stock is not suitable for continued listing under Sections 1001, 1002(e), 1003 and 1007 of the NYSE American Company Guide and will commence proceedings to delist the shares from NYSE American.
Trading in the common stock had already been halted on June 25, 2026, and the Exchange has now suspended trading effective immediately. Northann expects its shares to begin quotation on the OTC Markets under the symbol “NCLX”, possibly as soon as August 24, 2026. The company warns that OTC quotation is significantly more limited than NYSE American and may lead to reduced liquidity, potential pressure on the trading price, greater difficulty raising capital, and challenges in using equity incentives. Northann has the right to seek review of the delisting decision by the Exchange’s Listings Qualifications Panel and is evaluating whether to pursue this appeal.
Positive
- None.
Negative
- NYSE American delisting proceedings have been initiated against Northann’s common stock, with trading already suspended, which the company states may reduce liquidity, depress the share price, and make raising capital and granting equity incentives more difficult.
- The company expects to move to the OTC Markets, which it describes as significantly more limited than NYSE American and potentially unable to support sufficient trading volume for efficient trading.
Filing Explained
The filing leaves the SEC delisting unresolved: NYSE American says it will apply to the SEC only after applicable procedures, including any appeal, so the disclosed process has begun but is not yet complete.
8-K Event Classification
2 items: 3.01, 9.01
2 items
Item 3.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Securities
The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Trading halt date: June 25, 2026
Delisting notice date: August 21, 2026
Expected OTC quotation start: August 24, 2026
+1 more
4 metrics
Trading halt date
June 25, 2026
Date trading of Northann’s common stock was halted on NYSE American
Delisting notice date
August 21, 2026
Date NYSE Regulation notified Northann of unsuitability for continued listing
Expected OTC quotation start
August 24, 2026
Earliest date Northann expects quotation on OTC Markets under symbol “NCLX”
New trading symbol
NCLX
Expected symbol for Northann’s common stock on OTC Markets
Key Terms
NYSE Regulation, OTC Markets, Listings Qualifications Panel, Emerging growth company
4 terms
NYSE Regulation regulatory
"we received written notification (the “Notice”) from NYSE Regulation that the Company"
NYSE Regulation is the enforcement and oversight arm of the New York Stock Exchange that writes and applies the rules for listed companies and trading on the exchange. Think of it as a referee and rulebook combined: it monitors trading for wrongdoing, checks that companies meet listing and reporting requirements, and can fine or remove firms that break rules. Investors care because these actions help keep markets fair, reliable, and reduce the risk that a company’s shares become untradeable or lose credibility.
OTC Markets market
"We expect our common stock to begin quotation on the OTC Markets, under the symbol"
Over-the-counter (OTC) markets are trading venues where buyers and sellers deal directly through dealers or electronic networks instead of on a formal exchange; think of a neighborhood flea market versus a supermarket. They matter to investors because OTC-listed stocks often represent smaller or international companies with fewer reporting requirements, which can mean lower liquidity, wider price swings and higher risk but sometimes earlier access to growth opportunities.
Listings Qualifications Panel regulatory
"right to a review of NYSE Regulation’s determination to delist by the Listings Qualifications Panel"
A listings qualifications panel is a committee at a stock exchange or regulatory body that reviews whether a company continues to meet the exchange’s rules on finances, disclosure and governance. For investors it matters because the panel can require corrective actions, impose trading limits, or remove a stock from the exchange—moves that directly affect a company’s liquidity, market price and investors’ ability to buy or sell shares, like a quality-control inspector deciding if a product stays on the shelf.
Emerging growth company regulatory
"Emerging growth company x"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
What did Northann Corp. (NCL) announce about its NYSE American listing?
Northann disclosed that NYSE Regulation determined its common stock is not suitable for continued listing under Sections 1001, 1002(e), 1003 and 1007 of the NYSE American Company Guide and has begun proceedings to delist the shares, with trading already suspended.
When was Northann Corp. (NCL) trading halted and when was the delisting notice received?
Trading in Northann’s common stock was halted on June 25, 2026. The company then received a written delisting notice from NYSE Regulation on August 21, 2026, stating that its shares are not suitable for continued listing.
Where does Northann Corp. expect its stock to trade after NYSE American delisting?
Northann expects its common stock to begin quotation on the OTC Markets under the symbol “NCLX”, possibly as soon as August 24, 2026, though it cannot assure that trading or broker-dealer quotations will continue there.
Can Northann Corp. (NCL) appeal the NYSE American delisting decision?
Yes. Northann has the right to seek review of NYSE Regulation’s delisting determination by the Listings Qualifications Panel of the Exchange’s Committee for Review and is evaluating whether to pursue this appeal.
Will NYSE American seek SEC approval to delist Northann Corp. (NCL)?
Yes. The notice states that NYSE American will apply to the SEC to delist Northann’s common stock after completing applicable procedures, including any appeal the company might file.
AI-generated analysis. How Rhea-AI works. Not financial advice.
